EUVIMEDSkopri EUVIMED
EUVIMED · CrossrefJournal

CNS Drugs

ISSN 1172-7047 · Springer Science and Business Media LLC

Latest articles

  1. Preserving Neurological Function in People at High and Low Risk of Aggressive Multiple Sclerosis: An Observational Cohort Study

    Izanne Roos, Sifat Sharmin, Serkan Ozakbas, Raed Alroughani, Sara Eichau, Francois Grand’Maison, Cavit Boz, Jeannette Lechner-Scott, Katherine Buzzard, Alexandre Prat, Samia J. Khoury, Pierre Grammond, Anneke van der Walt, Yolanda Blanco, Matteo Foschi, Aysun Soysal, Michael Barnett, Julie Prevost, Murat Terzi, Oliver Gerlach, Richard Macdonell, Maria Jose Sa, Daniele Spitaleri, Guy Laureys, Vincent van Pesch, Nevin John, Elisabetta Cartechini, Riadh Gouider, Davide Maimone, Cristina Ramo-Tello, Suzanne Hodgkinson, Mark Slee, Pamela McCombe, Justin Garber, Jose Luis Sanchez-Menoyo, Abdullah Al-Asmi, Allan G. Kermode, Emmanuelle Lapointe, Vahid Shaygannejad, Bart Van Wijmeersch

    Published: 2026-07DOI: 10.1007/s40263-026-01287-8

  2. Effect of DL-3-n-Butylphthalide on Cerebral Hypoperfusion Due to Atherosclerotic Stenosis: A Multicenter, Double-Blind, Randomized Controlled, Preliminary Trial

    Dawei Chen, Xinxin Chang, Bei Pan, Yumeng Li, Feng Qiu, Yonghong Tang, Xiaoping Gao, Yanwei Yin, Fen Yang, Yu Wang, Jiang Zhang, Minghua Wang, Zhengyu Zhu, Yanping Guo, Degang Sun, Wensheng Tian, Hui Yu, Yafen Wei, Yadong Yu, Yi Zhao, Manli Sun, Youwen Hou, Hongying Li, Saizhen Wu, Xiangsheng Li, Xiaoxuan Ma, Feng Huang, Xiaoyan Yan, Jian Wu, Fei Wang, KeYun Liu, Jinsheng Lin, Changlin Wang, Haisheng Zhu, Xiaofan Pan, Jun Chang, Bo Zhang, Xiangyang Zhu, Bixia Huang, XiuFang Dong

    Published: 2026-07DOI: 10.1007/s40263-026-01293-w

Volumes

2026 · 1112025 · 1042024 · 752023 · 792022 · 962021 · 982020 · 912019 · 972018 · 1012017 · 892016 · 912015 · 832014 · 922013 · 1052012 · 822011 · 842010 · 762009 · 922008 · 752007 · 892006 · 992005 · 892004 · 1042003 · 902002 · 782001 · 742000 · 691999 · 841998 · 871997 · 971996 · 921995 · 941994 · 88

Għarfien li jaqbel max-xogħol tiegħek.

Minn bidu b’xejn u riċerka personali tal-letteratura sal-Research Suite sħiħa.

Ara t-tariffi →

Il-full texts kollha tal-pubblikaturi huma inklużi?

Le. Ir-referenzi biblijografiċi, l-astratti u t-testi sħaħ huma kontenuti differenti. Jekk test sħiħ huwiex disponibbli jiddependi mis-sors, Open Access u l-liċenzji eżistenti tiegħek. Pjan ta’ EUVIMED ma jissostitwix drittijiet addizzjonali tal-pubblikaturi.